| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $129.2M | -9.6% |
| Cost of Revenue | $96.4M | -13.4% |
| Gross Profit | $32.8M | +3.9% |
| R&D Expense | $7.2M | -48.2% |
| SG&A Expense | $17.2M | -19.2% |
| Operating Income | -$8.9M | +67.4% |
| Pre-tax Income | -$22.3M | +47.8% |
| Income Tax | -$1.9M | -251.2% |
| Net Income | -$20.4M | +53.6% |
| EPS (Basic) | -$13.69 | -317.4% |
| EPS (Diluted) | -$13.69 | -317.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | -63.3% |
| Accounts Receivable | $21.9M | -4.3% |
| Current Assets | $30.6M | -25.0% |
| Total Assets | $43.7M | -19.3% |
| Current Liabilities | $90.1M | +139.7% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $90.1M | +5.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | +76.1% |
| Investing Cash Flow | -$5.2M | -120.9% |
| Financing Cash Flow | $3.6M | +120.1% |
| -$46.4M |
| -46.7% |